Wanggang Tang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Wanggang Tang has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
Haonan Xu
Bengbu Medical University Key Laboratory of Cancer Research and Clinical Laboratory Diagnosis, School of Laboratory Medicine Bengbu Medical University Bengbu China
3 shared publicationsJianrong Chang
Bengbu Medical University Key Laboratory of Cancer Research and Clinical Laboratory Diagnosis, School of Laboratory Medicine, Bengbu Medical University, Bengbu, 233030, China; Scientific Research Center, Bengbu Medical University, Bengbu, 233030, China
3 shared publicationsJiatong Zhao
Bengbu Medical University Key Laboratory of Cancer Research and Clinical Laboratory Diagnosis, School of Laboratory Medicine, Bengbu Medical University, Bengbu, 233030, China
3 shared publicationsShuping Fei
Bengbu Medical University Key Laboratory of Cancer Research and Clinical Laboratory Diagnosis, School of Laboratory Medicine, Bengbu Medical University, Bengbu 233030, Anhui Province, China
3 shared publicationsWenwen Wu
Bengbu Medical University Key Laboratory of Cancer Research and Clinical Laboratory Diagnosis, School of Laboratory Medicine, Bengbu Medical University, Bengbu, 233030, China
3 shared publicationsChaoqun Lian
Bengbu Medical University Key Laboratory of Cancer Research and Clinical Laboratory Diagnosis, School of Laboratory Medicine Bengbu Medical University Bengbu China
2 shared publications
Latest Publications
- 16 March 2026
- Published by Elsevier in Protein Expression and Purification
- Vol. 241, 106919
Biophysical characterization of heterologously expressed GrpE and bioinformatic analysis of its native sequence from Neisseria gonorrhoeae
- 16 March 2026
- Published by Elsevier in Protein Expression and Purification
- Vol. 241, 106919
Biophysical characterization of heterologously expressed GrpE and bioinformatic analysis of its native sequence from Neisseria gonorrhoeae
- 27 September 2025
- Published by Elsevier in Protein Expression and Purification
- Vol. 237, 106824
Biochemical characterization of histidinol dehydrogenase from the human pathogen Neisseria gonorrhoeae
- 27 September 2025
- Published by Elsevier in Protein Expression and Purification
- Vol. 237, 106824
Biochemical characterization of histidinol dehydrogenase from the human pathogen Neisseria gonorrhoeae
- 4 February 2025
- Published by Elsevier in Protein Expression and Purification
- Vol. 229, 106687
Expression and biochemical characterization of a novel NAD+-dependent xylitol dehydrogenase from the plant endophytic fungus Trichoderma gamsii
- 4 February 2025
- Published by Elsevier in Protein Expression and Purification
- Vol. 229, 106687
Expression and biochemical characterization of a novel NAD+-dependent xylitol dehydrogenase from the plant endophytic fungus Trichoderma gamsii
- 21 April 2024
- Published by Wiley in Journal of Basic Microbiology
- Vol. 64 (6) , e202300751
The critical role of residues Phe120 and Val161 of (2 R,3 R)‑2,3‑butanediol dehydrogenase from Neisseria gonorrhoeae as probed by molecular docking and site‐directed mutagenesis
NAD+‐dependent (2 R,3 R)‑2,3‑butanediol dehydrogenase (BDH) from Neisseria gonorrhoeae (NgBDH) is a representative member of the medium‐chain dehydrogenase/reductase (MDR) superfamily. To date, little information is available on the substrate binding sites and catalytic residues of BDHs from this superfamily. In this work, according to molecular docking studies, we found that conserved residues Phe120 and Val161 form strong hydrophobic interactions with both (2 R,3 R)‑2,3‑butanediol (RR‐BD) and meso‐2,3‑butanediol (meso‐BD) and that mutations of these residues to alanine or threonine impair substrate binding. To further evaluate the roles of these two residues, Phe120 and Val161 were mutated to alanine or threonine. Kinetic analysis revealed that, relative to those of wild type, the apparent KM values of the Phe120Ala mutant for RR‐BD and meso‐BD increased 36‐ and 369‐fold, respectively; the catalytic efficiencies of this mutant with RR‐BD and meso‐BD decreased approximately 586‐ and 3528‐fold, respectively; and the apparent KM values of the Val161Ala mutant for RR‐BD and meso‐BD increased 4‐ and 37‐fold, respectively, the catalytic efficiencies of this mutant with RR‐BD and meso‐BD decreased approximately 3‐ and 28‐fold, respectively. Additionally, the Val161Thr mutant slightly decreased catalytic efficiencies (twofold with RR‐BD; 7.3‐fold with meso‐BD) due to an increase in KM (sixfold for RR‐BD; 24‐fold for meso‐BD) and a slight increase (2.8‐fold with RR‐BD; 3.3‐fold with meso‐BD) in kcat. These findings validate the critical roles of Phe120 and Val161 of NgBDH in substrate binding and catalysis. Overall, the current study provides a better understanding of the substrate binding and catalysis of BDHs within the MDR superfamily.
- 21 April 2024
- Published by Wiley in Journal of Basic Microbiology
- Vol. 64 (6) , e202300751
The critical role of residues Phe120 and Val161 of (2 R,3 R)‑2,3‑butanediol dehydrogenase from Neisseria gonorrhoeae as probed by molecular docking and site‐directed mutagenesis
NAD+‐dependent (2 R,3 R)‑2,3‑butanediol dehydrogenase (BDH) from Neisseria gonorrhoeae (NgBDH) is a representative member of the medium‐chain dehydrogenase/reductase (MDR) superfamily. To date, little information is available on the substrate binding sites and catalytic residues of BDHs from this superfamily. In this work, according to molecular docking studies, we found that conserved residues Phe120 and Val161 form strong hydrophobic interactions with both (2 R,3 R)‑2,3‑butanediol (RR‐BD) and meso‐2,3‑butanediol (meso‐BD) and that mutations of these residues to alanine or threonine impair substrate binding. To further evaluate the roles of these two residues, Phe120 and Val161 were mutated to alanine or threonine. Kinetic analysis revealed that, relative to those of wild type, the apparent KM values of the Phe120Ala mutant for RR‐BD and meso‐BD increased 36‐ and 369‐fold, respectively; the catalytic efficiencies of this mutant with RR‐BD and meso‐BD decreased approximately 586‐ and 3528‐fold, respectively; and the apparent KM values of the Val161Ala mutant for RR‐BD and meso‐BD increased 4‐ and 37‐fold, respectively, the catalytic efficiencies of this mutant with RR‐BD and meso‐BD decreased approximately 3‐ and 28‐fold, respectively. Additionally, the Val161Thr mutant slightly decreased catalytic efficiencies (twofold with RR‐BD; 7.3‐fold with meso‐BD) due to an increase in KM (sixfold for RR‐BD; 24‐fold for meso‐BD) and a slight increase (2.8‐fold with RR‐BD; 3.3‐fold with meso‐BD) in kcat. These findings validate the critical roles of Phe120 and Val161 of NgBDH in substrate binding and catalysis. Overall, the current study provides a better understanding of the substrate binding and catalysis of BDHs within the MDR superfamily.
- 21 November 2023
- Published by Springer Nature in Molecular Biotechnology
- Vol. 66 (12) , 3559-3572
Expression, Purification, and Bioinformatic Prediction of Mycobacterium tuberculosis Rv0439c as a Potential NADP+-Retinol Dehydrogenase
Although the genome of Mycobacterium tuberculosis (Mtb) H37Rv, the causative agent of tuberculosis, has been repeatedly annotated and updated, a range of proteins from this human pathogen have unknown functions. Mtb Rv0439c, a member of the short-chain dehydrogenase/reductases superfamily, has yet to be cloned and characterized, and its function remains unclear. In this work, we present for the first time the optimized expression and purification of this enzyme, as well as bioinformatic analysis to unveil its potential coenzyme and substrate. Optimized expression in Escherichia coli yielded soluble Rv0439c, while certain tag fusions resulted in insolubility. Sequence and docking analyses strongly suggested that Rv0439c has a clear preference for NADP+, with Arg53 being a key residue that confers coenzyme specificity. Furthermore, functional prediction using CLEAN and DEEPre servers suggested that this protein is a potential NADP+-retinol dehydrogenase (EC No. 1.1.1.300) in retinol metabolism, and this was supported by a BLASTp search and docking studies. Collectively, our findings provide a solid basis for future functional characterization and structural studies of Rv0439c, which will contribute to enhanced understanding of Mtb biology.
- 21 November 2023
- Published by Springer Nature in Molecular Biotechnology
- Vol. 66 (12) , 3559-3572
Expression, Purification, and Bioinformatic Prediction of Mycobacterium tuberculosis Rv0439c as a Potential NADP+-Retinol Dehydrogenase
Although the genome of Mycobacterium tuberculosis (Mtb) H37Rv, the causative agent of tuberculosis, has been repeatedly annotated and updated, a range of proteins from this human pathogen have unknown functions. Mtb Rv0439c, a member of the short-chain dehydrogenase/reductases superfamily, has yet to be cloned and characterized, and its function remains unclear. In this work, we present for the first time the optimized expression and purification of this enzyme, as well as bioinformatic analysis to unveil its potential coenzyme and substrate. Optimized expression in Escherichia coli yielded soluble Rv0439c, while certain tag fusions resulted in insolubility. Sequence and docking analyses strongly suggested that Rv0439c has a clear preference for NADP+, with Arg53 being a key residue that confers coenzyme specificity. Furthermore, functional prediction using CLEAN and DEEPre servers suggested that this protein is a potential NADP+-retinol dehydrogenase (EC No. 1.1.1.300) in retinol metabolism, and this was supported by a BLASTp search and docking studies. Collectively, our findings provide a solid basis for future functional characterization and structural studies of Rv0439c, which will contribute to enhanced understanding of Mtb biology.
- 24 March 2021
- Published by Springer Nature in Molecular Biotechnology
- Vol. 63 (6) , 491-501
Purification and Characterization of (2R,3R)-2,3-Butanediol Dehydrogenase of the Human Pathogen Neisseria gonorrhoeae FA1090 Produced in Escherichia coli
2,3-Butanediol dehydrogenase (BDH), also known as acetoin/diacetyl reductase, is a pivotal enzyme for the formation of 2,3-butanediol (2,3-BD), a chiral compound with potential roles in the virulence of certain pathogens. Here, a NAD(H)-dependent (2R,3R)-BDH from Neisseria gonorrhoeae FA1090 (NgBDH), the causative agent of gonorrhoea, was functionally characterized. Sequence analysis indicated that it belongs to zinc-containing medium-chain dehydrogenase/reductase family. The recombinant NgBDH migrated as a single band with a size of around 45 kDa on SDS-PAGE and could be confirmed by Western blotting and mass spectrometry. For the oxidation of either (2R,3R)-2,3-BD or meso-2,3-BD, the enzyme exhibited a broad pH optimum between pH 9.5 to 11.5. For the reduction of (3R/3S)-acetoin, the pH optimum was around 6.5. The enzyme could catalyze the stereospecific oxidation of (2R,3R)-2,3-BD (Km = 0.16 mM, kcat/Km = 673 s−1 · mM−1) and meso-BD (Km = 0.72 mM, kcat/Km = 165 s−1 · mM−1). Moreover, it could also reduce (3R/3S)-acetoin with a Km of 0.14 mM and a kcat/Km of 885 s−1 · mM−1. The results presented here contribute to understand the 2,3-BD metabolism in N. gonorrhoeae and pave the way for studying the influence of 2,3-BD metabolism on the virulence of this pathogen in the future.
- 24 March 2021
- Published by Springer Nature in Molecular Biotechnology
- Vol. 63 (6) , 491-501
Purification and Characterization of (2R,3R)-2,3-Butanediol Dehydrogenase of the Human Pathogen Neisseria gonorrhoeae FA1090 Produced in Escherichia coli
2,3-Butanediol dehydrogenase (BDH), also known as acetoin/diacetyl reductase, is a pivotal enzyme for the formation of 2,3-butanediol (2,3-BD), a chiral compound with potential roles in the virulence of certain pathogens. Here, a NAD(H)-dependent (2R,3R)-BDH from Neisseria gonorrhoeae FA1090 (NgBDH), the causative agent of gonorrhoea, was functionally characterized. Sequence analysis indicated that it belongs to zinc-containing medium-chain dehydrogenase/reductase family. The recombinant NgBDH migrated as a single band with a size of around 45 kDa on SDS-PAGE and could be confirmed by Western blotting and mass spectrometry. For the oxidation of either (2R,3R)-2,3-BD or meso-2,3-BD, the enzyme exhibited a broad pH optimum between pH 9.5 to 11.5. For the reduction of (3R/3S)-acetoin, the pH optimum was around 6.5. The enzyme could catalyze the stereospecific oxidation of (2R,3R)-2,3-BD (Km = 0.16 mM, kcat/Km = 673 s−1 · mM−1) and meso-BD (Km = 0.72 mM, kcat/Km = 165 s−1 · mM−1). Moreover, it could also reduce (3R/3S)-acetoin with a Km of 0.14 mM and a kcat/Km of 885 s−1 · mM−1. The results presented here contribute to understand the 2,3-BD metabolism in N. gonorrhoeae and pave the way for studying the influence of 2,3-BD metabolism on the virulence of this pathogen in the future.